A similar measurement was conducted in twenty-eight COVID-19 adult patients (mean age = 66, age range 18–89) in which only 35.7% of them evidenced the presence of ocular anti-SARS-CoV-2 IgA [27]. The gene discussed is CD79A; the disease is COVID-19.